These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33283964)

  • 1. An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile.
    Piper T; Heimbach S; Adamczewski M; Thevis M
    Drug Test Anal; 2021 May; 13(5):916-928. PubMed ID: 33283964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontargeted detection of designer androgens: Underestimated role of in vitro bioassays.
    Lund RA; Cooper ER; Wang H; Ashley Z; Cawley AT; Heather AK
    Drug Test Anal; 2021 May; 13(5):894-902. PubMed ID: 33864649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell-free bioassay for the detection of androgens.
    Cooper ER; Hughes G; Kauff A; Sutherland E; Ashley Z; Heather AK
    Drug Test Anal; 2021 May; 13(5):903-915. PubMed ID: 33709622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
    Clarke A; Scarth J; Teale P; Pearce C; Hillyer L
    Drug Test Anal; 2011 Jan; 3(1):74-87. PubMed ID: 21322180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
    Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
    Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous steroid profiling in the athlete biological passport.
    Sottas PE; Saugy M; Saudan C
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):59-73, viii-ix. PubMed ID: 20122450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control.
    Cha E; Kim S; Kim HJ; Lee KM; Kim KH; Kwon OS; Lee J
    Drug Test Anal; 2015; 7(11-12):1040-9. PubMed ID: 26489966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.
    Cadwallader AB; Lim CS; Rollins DE; Botrè F
    J Anal Toxicol; 2011 Nov; 35(9):594-607. PubMed ID: 22080898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
    McKinney AR
    Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.
    Ponzetto F; Parasiliti-Caprino M; Gesmundo I; Marinelli L; Nonnato A; Nicoli R; Kuuranne T; Mengozzi G; Ghigo E; Settanni F
    Talanta; 2023 Apr; 255():124218. PubMed ID: 36603442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs.
    Bailey K; Yazdi T; Masharani U; Tyrrell B; Butch A; Schaufele F
    PLoS One; 2016; 11(3):e0151860. PubMed ID: 26998755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens, sports, and detection strategies for anabolic drug use.
    Walpurgis K; Piper T; Thevis M
    Best Pract Res Clin Endocrinol Metab; 2022 Jul; 36(4):101609. PubMed ID: 35120801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.
    Thevis M; Krug O; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2017 Aug; 31(15):1290-1296. PubMed ID: 28508503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping.
    Cawley AT; George AV
    Drug Test Anal; 2012 Dec; 4(12):897-911. PubMed ID: 22791679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the detection of anabolic steroid esters in human serum by LC-MS.
    de la Torre X; Iannone M; Botrè F
    J Pharm Biomed Anal; 2021 Feb; 194():113807. PubMed ID: 33281003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.